3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
24
Colorectal Neoplasms
19
Rectal Neoplasms
11
Stomach Neoplasms
9
Colonic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Carcinoma, Hepatocellular
7
Neoplasm Metastasis
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasms
5
Liver Neoplasms
5
Esophageal Neoplasms
5
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Osteosarcoma
4
Cholangiocarcinoma
4
Peritoneal Neoplasms
3
Ovarian Neoplasms
3
Neuroblastoma
3
Multiple Myeloma
3
Lung Neoplasms
3
Locally Advanced Rectal Cancer
3
Kidney Neoplasms
3
Inflammatory Breast Neoplasms
3
Turcot syndrome
2
Sarcoma
2
Pancreatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Head and Neck Neoplasms
2
Glioblastoma
2
Interventions
Amplified Fragment Length Polymorphism Analysis
2
entrectinib
1
Vinorelbine
1
Trastuzumab
1
Radiomics
1
Pharmacogenomic Testing
1
Neoadjuvant Therapy
1
Molecular Diagnostic Techniques
1
Letrozole
1
Goserelin
1
Gene Expression Profiling
1
Epirubicin
1
Docetaxel
1
Cyclophosphamide
1
Capecitabine
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma, Lobular
×
Neoadjuvant Therapy
×
Clear all
NCT01641406
2012-07-16
NACprotocol
Auxilio Mutuo Cancer Center
Phase 2
Unknown
60 enrolled